The medication's primary mechanism activates appetite-suppression centers in your hypothalamus and slows gastric emptyingboth processes occur whether your stomach is full or empty
The information provided has been reviewed by licensed healthcare professionals but shouldn't replace a consultation with your physician
The standard of care for type 2 diabetes in the UK follows a structured approach beginning with lifestyle modification, followed by metformin as first-line pharmacotherapy, with additional agents added according to individualised treatment algorithms as outlined in NICE guideline NG28
AOD 9604 , a fragment of human growth hormone, targets fat metabolism through entirely different pathways than GLP-1 signaling
August 2025 : The US FDA approved Wegovy (semaglutide 2.4 mg) for the treatment of noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) in adults with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis), in combination with a reduced-calorie diet and increased physical activity
Wang L, Wang Z, Lan Y, Tuo Y, Ma S, Liu X
